Antibacterial liquid dressing combined with standard polyurethane transparent dressing (SPU) and SPU for prevent catheter-related bloodstream infection: a randomized controlled trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800019929

Enrollment

Unknown

Registered

2018-12-09

Start date

2018-12-10

Completion date

Unknown

Last updated

2018-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

catheter-related blood stream infection

Interventions

Experimental group:antibacterial liquid dressing, Sticking and Fixing with Standard Polyurethane Transparent Dressing

Control group:Sticking and Fixing with Standard Polyurethane Transparent Dressing

Eligibility

Sex/Gender

All

Age

18 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. It is necessary with indwelling CVC by decision of attending doctor; 2. The operation of indwelling CVC in participate units; 3. Expected survival time > 48h; 4. Aged at least 18 years; 5. Ability to follow the study and follow-up procedures; 6. Subject/relative/guardian understands the willingness and signs the informed consent.

Exclusion criteria

Exclusion criteria: 1. Hospitalization time < 48h; 2. Indmelling CVC time < 48h; 3. Malignant blood diseases; 4. Human immunodeficiency virus infection (HIV); 5. Undergoing chemotherapy or radiotherapy; 6. Sepsis was diagnosed on admission or catheter-related infection was defined in the old catheter after new catheter; 7. The patient has a serious infection before admission and has not recovered after treatment with high-dose antibiotics; 8. Those who received high-dose of hormone in recently one month or long-term hormone therapy before enrollment; 9. Intravascular foreign body (such as pacemakers and artificial heart valves); 10. Allergy to antibacterial liquid dressing or habitus of severe allergy; 11. The researchers believe that certain conditions of patients may affect the efficacy and safety evaluation of this study; 12. Patients/relatives/guardians lack basic compliance with this study.

Design outcomes

Primary

Measure	Time frame
catheter-related bloodstream infection;30 days survival status;blood culture;	—

Secondary

Measure	Time frame
skin microbiological culture;indication of infection and inflammation;	—

Countries

China

Contacts

Public ContactShaoling LIAO

Affiliated Hospital of Guangdong Medical University

lshl829@163.com+86 13802821780

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026